Asma Patel

The biotech sector is the only area expected to experience an increase in job vacancies in 2024, with a projected rise of 5.9% compared to 2023. 📈 Want to dive deeper into the data and uncover more insights? Download the full report by Cpl Life Sciences and Vacancysoft for comprehensive data-driven analysis that will help you stay ahead of the curve: https://zurl.co/wBWp #JobMarket #RegulatoryAffairs #LifeSciences

1

As Claire Long says below, keeping patients at the heart of our work is core to what we do at 90TEN.   You can read more from Claire and our Envision Pharma Group colleague Simon Stones on the value of incorporating patient and caregiver insights into the drug development process in the current edition of PharmaTimes Magazine 👇   #HealthcareComms #PatientInsights #PatientAdvocacy

12

The Top Ten Branded searches on the WaveData Live system are an interesting indicator of the focus areas for key players in the UK Pharma sector. Here's the countdown for April 2024........ You can see the Top Ten Brand searches, alongside other industry insights in the latest WaveData Bulletin. www.wavedata.co.uk/kb #pharmapricing #pharmatopten #wavedatabulletin

7

Island Pharmaceuticals is pleased to report highly positive pharmacokinetic (PK) data for ISLA-101 from its 24-subject Single Ascending Dose clinical study. The new data shows that the required levels of ISLA-101 concentration in the blood were observed after only a single dose. PK data is critical for determining how the drug acts in the body and for establishing appropriate dosing regimens for Island's planned Phase 2a clinical trial. CEO Dr David Foster said, “This new pharmacokinetic data reinforces our strong confidence in ISLA-101. The data has shown us that even following a single dose, we are achieving blood concentrations that have previously been shown to be effective against dengue fever infections. This is exactly the outcome we hoped for - it provides a critical datapoint to underpin our dosing regimen as we prepare for the Phase 2 clinical study, which will include dosing for multiple days.” For further information, refer to the full ASX Announcement here: https://shorturl.at/nqyO8 #ILA #DengueFever #MosquitoBorneViruses

38

2 Comments

An integral part of the existing science and technology ecosystem, it is important to understand the role of CRO’s, CMO’s & CDMO’s in the Pharma and Biotech Industry. This latest article from our specialist team discusses their significance, the difference between them and the implications for the fit out industry. We are pleased to have worked with a number of these organisations, designing and delivering facilities which allow them efficiently reach their goals. Read the article by Dr Manisha Kulkarni here: https://lnkd.in/e29g_DZ3

32

UK drug discovery needs stronger funding effort, report shows Improvements to the ways medicines are discovered are essential for the future health of patients, a new report by Medicines Discovery Catapult (MDC) shows.  The State of the Discovery Nation (SODN) 2024: ‘Fostering a Dynamic, Sustainable Medicines Discovery Sector’ report states that the industry must work together to de-risk funding in drug discovery and attract more investors. https://lnkd.in/eH_-9XtJ #DrugDiscovery #Pharmaceutical #Biotechnology

11

1 Comment

Stepping into strategic planning for 2025? Here are our 6 invaluable tips that we've learnt whilst building and delivering exemplary plans with our biopharma and pharmaceutical partners. #StrategicExcellence #BioPharma #Pharmaceuticals #Strategy

6

2 Comments